Provided by Tiger Trade Technology Pte. Ltd.

Alkermes PLC

45.20
-1.5100-3.23%
Volume:564.19K
Turnover:25.91M
Market Cap:7.58B
PE:116.42
High:46.53
Open:46.51
Low:45.12
Close:46.71
52wk High:55.67
52wk Low:26.99
Shares:167.76M
Float Shares:155.00M
Volume Ratio:1.26
T/O Rate:0.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3882
EPS(LYR):1.43
ROE:3.85%
ROA:4.20%
PB:4.19
PE(LYR):31.61

Loading ...

Alkermes Schedules Second-quarter Results Call and Webcast

Reuters
·
Jul 15

Alkermes to Report Second Quarter Financial Results on July 28, 2026

THOMSON REUTERS
·
Jul 15

Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Jul 14

Alkermes Plc : TD Cowen Raises Target Price to $57 from $50

THOMSON REUTERS
·
Jul 13

Alkermes Price Target Announced at $60.00/share by JP Morgan

Dow Jones
·
Jul 13

Alkermes Says Alixorexton Sustains Wakefulness Gains in Nine-month Narcolepsy Extension Study Interim Analysis

Reuters
·
Jul 13

Alkermes - Alixorexton Generally Well Tolerated at All Doses Tested

THOMSON REUTERS
·
Jul 13

Alkermes - Alixorexton Shows Sustained Improvement on Mwt and ESS at Week 24, Nine Months After First Dose

THOMSON REUTERS
·
Jul 13

Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults with Narcolepsy Type 1 and Type 2 in Long-term Extension Study Interim Analysis

THOMSON REUTERS
·
Jul 13

Bank of America Securities Remains a Sell on Alkermes (ALKS)

TIPRANKS
·
Jul 13

Alkermes Plc : JP Morgan Resumes Coverage with Neutral Rating; Target Price $60

THOMSON REUTERS
·
Jul 13

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Immunome (IMNM)

TIPRANKS
·
Jul 09

Is Alkermes (ALKS) Fully Priced As Russell 2000 Index Inclusion Draws Fresh Attention?

Simply Wall St.
·
Jul 09

Analysts Have Conflicting Sentiments on These Healthcare Companies: Evolus (EOLS), Alkermes (ALKS) and VolitionRX (VNRX)

TIPRANKS
·
Jul 08

Alkermes - no Penalties or Further Obligations Owed by Alkermes or Amneal After Agreement Termination - SEC Filing

THOMSON REUTERS
·
Jul 08

Alkermes - Co and Amneal Terminate Authorized Generic Product Supply Agreement on July 6, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 08

Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $109,882.02

Reuters
·
Jul 07

The Bull Case For Alkermes (ALKS) Could Change Following Vibrance-12 Data And Russell 2000 Inclusion

Simply Wall St.
·
Jul 04

Alkermes (ALKS) Gets a Buy from Mizuho Securities

TIPRANKS
·
Jul 02

Alkermes EVP R&D and Chief Medical Officer Craig C. Hopkinson Disposes of USD 463,233 in Common Shares

Reuters
·
Jul 02